These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
18. A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3. Renlund DG; O'Connell JB; Gilbert EM; Hammond ME; Burton NA; Jones KW; Karwande SV; Doty DB; Menlove RL; Herrick CM Transplantation; 1989 Apr; 47(4):599-605. PubMed ID: 2523099 [TBL] [Abstract][Full Text] [Related]
19. Delayed response to orthoclone OKT3 treatment for renal allograft rejection resistant to steroid and antilymphocyte globulin. Oh CS; Sollinger HW; Stratta RJ; Kalayoglu M; Belzer FO Transplantation; 1988 Jan; 45(1):65-7. PubMed ID: 3276065 [TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts. Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]